FactaeThe Factual News

Nanobiotix in strategic discussions with Johnson & Johnson

Nanobiotix and Johnson & Johnson are discussing a strategic collaboration.

Published 5h1 sourceNotableupdated 3h
Lire en français
≈ 14s

The fact

These talks could impact the biotech group's stock market valuation.

Financial forums are closely monitoring this potential alliance.

Click the link to read an article on the topic:
Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
FranceWorld map →
Follow topic →
Auto-synthesis from 1 media source · identified on August 22, 2026
← Back to home
Discover

Read more

All marches →
economie

Johnson & Johnson seals 5-billion-dollar deal with Nanobiotix

5sem · 1 sourcemarches

Johnson & Johnson opens clinical centers for Nanobiotix in Phase 3

3j · 1 sourcemarches

Nanobiotix approaches 2019 record, biotech stock rebounds

10sem · 1 sourcemarches

Nanobiotix sees strong gains on stock market forums

2sem · 1 sourcemarches

NANOBIOTIX presents major clinical trial results

13sem · 1 sourcemarches100 million dollars

Nanobiotix receives takeover offer valued at 100 million dollars

12sem · 1 source